핵산 분리 및 정제 시장 : 제품별, 유형별, 방법별, 용도별, 최종 용도별, 세계 예측(2024-2032년)

Global Nucleic Acid Isolation & Purification Market will demonstrate a 7.7% CAGR from 2024 to 2032, propelled by technological advancements, particularly the introduction of automated purification systems. These innovations enhance efficiency, providing faster and more accurate nucleic acid extraction. As industries increasingly rely on genomics for applications like personalized medicine and drug discovery, the demand for advanced purification technologies is rising. The intersection of automation and genomics streamlines processes and will contribute significantly to shaping the market size.

For instance, in 2022, MP Biomedicals unveiled the MPure-32, the 3rd generation of automated nucleic acid purification, marking a significant advancement in purification technology. This launch signifies a substantial enhancement in purification technology, bolstering the Nucleic Acid Isolation & Purification market with advanced and efficient automated systems.

The nucleic acid isolation & purification industry is classified based on application, end-use, and region.

The drug discovery and development segment will garner remarkable gains through 2032, attributed to the critical role of nucleic acid analysis in pharmaceutical research. As drug development increasingly relies on genomics and molecular biology, the demand for efficient nucleic acid isolation and purification solutions will surge. This segment's prominence is underscored by its vital contribution to advancing precision medicine and therapeutic innovation, positioning it as a key driver in shaping the market outlook.

The contract research organization segment will achieve noteworthy nucleic acid isolation & purification market share by 2032 due to the increasing outsourcing of research activities and the growing demand for specialized services in genomics and molecular biology. As pharmaceutical and biotechnology companies increasingly rely on CROs for nucleic acid-related services, this segment will emerge as a vital contributor to market growth. The CRO sector's expertise and efficiency will position it at the forefront of advancing nucleic acid isolation and purification technologies.

Asia-Pacific nucleic acid isolation & purification industry will grow at a notable CAGR from 2024 to 2032, driven by the region's advancing healthcare infrastructure, burgeoning biotechnology sector, and increasing investments in research and development. With a rising focus on genomics and personalized medicine, the demand for efficient nucleic acid isolation technologies in APAC will surge. The region's dynamic market landscape, characterized by technological innovations and expanding biopharmaceutical activities, will position it as a pivotal contributor to the nucleic acid isolation & purification market.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Data validation
• 1.5 Data sources
  • 1.5.1 Primary
  • 1.5.2 Secondary
    • 1.5.2.1 Paid sources
    • 1.5.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Nucleic acid isolation & purification industry 360 degree synopsis, 2018 - 2032 (USD Million)
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Product trends
  • 2.1.4 Type trends
  • 2.1.5 Method trends
  • 2.1.6 Application trends
  • 2.1.7 End-use trends

Chapter 3 Nucleic Acid Isolation & Purification Market Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising demand for molecular diagnostics
    • 3.2.1.2 Advancements in biotechnology and genomics research
    • 3.2.1.3 Rise in the adoption of personalized medicine
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of reagents and consumables
    • 3.2.2.2 Lack of standardization across laboratories
• 3.3 Growth potential analysis
  • 3.3.1 By product
  • 3.3.2 By type
  • 3.3.3 By method
  • 3.3.4 By application
  • 3.3.5 By end-use
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Strategic dashboard, 2022

Chapter 5 Nucleic Acid Isolation & Purification Market Estimates and Forecast, By Product, 2018-2032 (USD Million)

• 5.1 Key trends, by product
• 5.2 Reagents & kits
• 5.3 Instruments

Chapter 6 Nucleic Acid Isolation & Purification Market Estimates and Forecast, By Type, 2018-2032 (USD Million)

• 6.1 Key trends, by type
• 6.2 RNA isolation & purification
  • 6.2.1 mRNA isolation & purification
  • 6.2.2 miRNA isolation & purification
  • 6.2.3 Total RNA isolation & purification
  • 6.2.4 Other RNA isolation & purification types
• 6.3 DNA isolation & purification
  • 6.3.1 Genomic DNA isolation & purification
  • 6.3.2 Plasmid DNA isolation & purification
  • 6.3.3 Viral DNA isolation & purification
  • 6.3.4 Other DNA isolation & purification types

Chapter 7 Nucleic Acid Isolation & Purification Market Estimates and Forecast, By Method, 2018-2032 (USD Million)

• 7.1 Key trends, by method
• 7.2 Magnetic beads
• 7.3 Column-based
• 7.4 Reagent-based
• 7.5 Other methods

Chapter 8 Nucleic Acid Isolation & Purification Market Estimates and Forecast, By Application, 2018-2032 (USD Million)

• 8.1 Key trends, by application
• 8.2 Diagnostics
• 8.3 Drug discovery & development
• 8.4 Precision medicine
• 8.5 Other applications

Chapter 9 Nucleic Acid Isolation & Purification Market Estimates and Forecast, By End-use, 2018-2032 (USD Million)

• 9.1 Key trends, by end-use
• 9.2 Hospitals and diagnostic centers
• 9.3 Pharmaceutical & biotechnology companies
• 9.4 Contract research organizations
• 9.5 Other end-users

Chapter 10 Nucleic Acid Isolation & Purification Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

• 10.1 Key trends, by region
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 Rest of Asia Pacific
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Rest of Latin America
• 10.6 Middle East & Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 Rest of Middle East & Africa

Chapter 11 Company Profiles

• 11.1 QIAGEN N.V.
• 11.2 Thermo Fisher Scientific Inc.
• 11.3 Illumina Inc.
• 11.4 Danaher Corporation
• 11.5 F. Hoffmann La Roche Ltd
• 11.6 Merck KGaA
• 11.7 Agilent Technologies Inc.
• 11.8 Bio-Rad Laboratories
• 11.9 Takara Bio Inc.
• 11.10 Promega Corporation
• 11.11 New England Biolabs
• 11.12 Abcam plc.
• 11.13 PCR Biosystems